Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Stealth Particles to Target Tumors

Abstract:
Stealth targeting drug delivery system could also deliver genes or gene fragments in gene therapy

Stealth Particles to Target Tumors

Washington, D.C. | August 31, 2005

Stealth nano particles may some day target tumor cells and deliver medication to specific body locations, according to Penn State chemical engineers.

"Mainly we have focused on chemotherapy drugs," says Dr. Michael Pishko, professor of chemical engineering and materials science and engineering. "But others are considering using this delivery system to deliver genes in gene therapy."

The researchers first produce nano-sized powders of the drug they wish to deliver and encapsulate them in a polymer nanoshell. The drug used for this project was paclitaxel - an anti breast cancer drug and dexamethasone - a steroid frequently used to treat eye inflammation. This shell allows the drug to travel in stealth mode through the bloodstream.

"A layer-by-layer self-assembly technique was used to encapsulate core charged drug nanoparticles in a polymeric nanoshell," the researchers told attendees today (Aug. 31) at the 230th American Chemical Society Meeting, Washington, D.C.

Normally, drugs, especially the toxic drugs used for chemotherapy, trigger the human immune system into action, but, with the polymer shell for protection, these drugs can circulate longer without being removed.

"If the drugs do not trigger an immune response, then lower levels of drug can be used than currently are necessary in chemotherapy," says Pishko.

The researchers, who include Pishko, Alisar Zahr and Cheryl A. Rumbarger, graduate students in chemical engineering, tested their nanoshell in cell culture and found that it had less phagocytosis removal of the drug during a 24-hour period than the unencapsulated drug.

Combined with longer retention in the body, the researchers engineered the nanoparticle shells to target specific cells by attaching a functionalized polymer to the shell. They designed this tentacle-like projection to target a receptor on a tumor cell, or a specific location in the eye, for example. Once the drug arrives via the blood to the tumor or eye, it attaches and slowly releases its contents.

This type of drug delivery system works especially well in such highly vascularized areas such as tumors and the eye, because the drug can travel right up to the target area. Delivery to areas in the brain would not be feasible because of the blood brain barrier that prevents foreign substances from moving from the blood into the cells of the brain.

"For targeting, we could exploit the fact that cancer tumors have a lot more folic acid receptors and target those," says Pishko. "We could also use specific monoclonal antibodies to target specific tumors."

The researchers also considered delivery of drugs to specific type cells, like those in the eye. This type of stealth targeting drug delivery system could also deliver genes or gene fragments in gene therapy.

The National Science Foundation funded this research.

####
Contact:
A'ndrea Elyse Messer
Science & Research Information Officer Penn State
814-865-9481
814-865-9421
aem1@psu.edu

Copyright Penn State

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Possible Futures

Nanotechnology in Medical Devices Market is expected to reach $8.5 Billion by 2019 March 25th, 2015

Nanotechnology Enabled Drug Delivery to Influence Future Diagnosis and Treatments of Diseases March 21st, 2015

Nanocomposites Market Growth, Industry Outlook To 2020 by Grand View Research, Inc. March 21st, 2015

Nanotechnology Drug Delivery Market in the US 2012-2016 : Latest Report Available by Radiant Insights, Inc March 16th, 2015

Self Assembly

Designer's toolkit for dynamic DNA nanomachines: Arm-waving nanorobot signals new flexibility in DNA origami March 27th, 2015

Four Scientists With Major Contributions to Research at Brookhaven Lab Named American Physical Society Fellows March 17th, 2015

Nanotubes self-organize and wiggle: Evolution of a nonequilibrium system demonstrates MEPP February 10th, 2015

Engineering self-assembling amyloid fibers January 26th, 2015

Nanomedicine

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

Nanomedicine shines light on combined force of nanomedicine and regenerative medicine March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

Announcements

Rutgers, NIST physicists report technology with potential for sub-micron optical switches March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Super sensitive measurement of magnetic fields March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE